Omar Nadeem

17PUBLICATIONS
201CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesRegenerative medicine (incl. stem cells)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 23, 2026
Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.

|Oct 13, 2026
Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy.

|Sep 12, 2026
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.

|Jun 03, 2026
Arlocabtagene autoleucel: a GPRC5D-targeted CAR T-cell therapy for heavily pretreated relapsed/refractory multiple myeloma.

|Apr 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

|Apr 21, 2026
eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies.

Pageof 3

Frequent Collaborators

8 joint publications

Irene M Ghobrial

7 joint publications

Adam S Sperling

6 joint publications

Shonali Midha

5 joint publications

Larry D Anderson